$GMRS

Hall Jessica sold $289K of GMRS

Hall Jessica (Chief Accounting Officer) sold 23,687 shares of GMR Solutions Inc. (GMRS) at $12.20 ($0.29M total) on 2026-09-14.

Original reporting
SEC EDGAR · Hall Jessica
Published Sep 15, 2026, 10:01 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 10:15 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GMRS
Bearish
medium confidence
Mentioned
$GMRS
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GMRSBearishLow
01

Why it matters

The disclosed sale is modest but may influence short‑term sentiment.

02

Market read

Insider sale adds a small data point for traders monitoring GMRS.

03

What to watch

Potential upcoming earnings or corporate actions not disclosed.

Relevance 4/10Novelty 3/10Timing: today

Background

Form 4 filings provide the first public record of insider transactions.

Company-level read

Ticker impact

$GMRSBearishMedium confidence
Context

Form 4 disclosed Chief Accounting Officer Hall Jessica sold 23,687 shares for $289K.

Expected impact

Potential modest downside of 1-2% if market reacts.

Evidence & confidence

Sale size is small relative to float, but insider role adds weight.

Market effects

Minimal impact on the broader technology services sector.

Limited to US markets where GMRS trades.

Low global relevance.

Counterpoint

Sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • GMR Solutions Inc.

    Issuer of the Form 4 filing.

  • Hall Jessica

    Chief Accounting Officer who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GMRSMed

GMR Solutions Inc. (GMRS): Results of Operations and Financial Condition

GMR Solutions Inc. (GMRS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ​ ​ GMR Solutions Inc. Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Reaffirms Full Year 2026 Guidance LEWISVILLE, Texas (August 12, 2026) — GMR Solutions Inc. (“GMR” or the “Company”) (NYSE: GMRS), the nation’s largest provider of em

$PBLSMed

Top Biotech Gainers: PBLS Soars Over 50%, CLOV Rallies On Legal Win, RNAZ, TMCI On Watch

Biotech stocks rose on varied catalysts. Parabilis (PBLS) debuted on Nasdaq, up 58% to $31.60 after pricing a $20.00 IPO of 33.5M shares for ~$670M gross proceeds. Clover Health (CLOV) gained 14% to $4.89 after a court ruling upgraded its 2026 PPO Star Rating to 4.5 from 3.5. Myomo (MYO) rose 17% to $1.54; Shoulder Innovations (SI) up 17% to $17.89; GMRS up 13% to $13.18.

$GMRSMedAI 9/10

Full Transcript: GMR Solutions Q1 2026 Earnings Call - GMR Solutions (NYSE:GMRS)

GMR Solutions (NYSE:GMRS) reported Q1 2026 revenue of $1.46 billion (+6.6% YoY) and adjusted EBITDA of $305 million (+9.7%). The company said its recent IPO leaves net leverage around 3.5x. It cited a 47% rise in 911 nurse navigation calls and nearly $47 million in incremental annualized revenue from new agreements. 2026 guidance targets $5.89–$6.18 billion revenue and high single-digit adjusted EBITDA growth.